Laddar...
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Treatment of chronic lymphocytic leukemia (CLL) has advanced with the introduction of chemoimmunotherapy (CIT) agents that have improved the outcomes of frontline therapy. However, most treated patients will relapse and require subsequent therapy. This review focuses on recent advances in the treatm...
Sparad:
| I publikationen: | Ann Hematol |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Berlin Heidelberg
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486803/ https://ncbi.nlm.nih.gov/pubmed/28389687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-017-2982-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|